Negrulj R - Search Results

1

Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.

Mooranian A, Negrulj R, Chen-Tan N, Fakhoury M, Arfuso F, Jones F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Artif Cells Nanomed Biotechnol. 2016;44(2):588-95. doi: 10.3109/21691401.2014.971806. Epub 2014 Oct 30. Artif Cells Nanomed Biotechnol. 2016. PMID: 25358121 Free article.

2

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations.

Mooranian A, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur TK, Mikov M, Lalic-Popovic M, Stojancevic M, Golocorbin-Kon S, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Pharm Dev Technol. 2015;20(6):702-9. doi: 10.3109/10837450.2014.915570. Epub 2014 May 5. Pharm Dev Technol. 2015. PMID: 24798888

3

Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells.

Mooranian A, Negrulj R, Arfuso F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Artif Cells Nanomed Biotechnol. 2016;44(1):194-200. doi: 10.3109/21691401.2014.934457. Epub 2014 Jul 11. Artif Cells Nanomed Biotechnol. 2016. PMID: 25014218 Free article.

4

Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.

Mooranian A, Negrulj R, Chen-Tan N, Al-Sallami HS, Fang Z, Mukkur T, Mikov M, Golocorbin-Kon S, Fakhoury M, Arfuso F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Drug Des Devel Ther. 2014 Jul 28;8:1003-12. doi: 10.2147/DDDT.S65396. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25114507 Free PMC article.

5

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment.

Mooranian A, Negrulj R, Al-Sallami HS, Fang Z, Mikov M, Golocorbin-Kon S, Fakhoury M, Arfuso F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. J Microencapsul. 2015;32(2):151-6. doi: 10.3109/02652048.2014.958204. Epub 2014 Sep 29. J Microencapsul. 2015. PMID: 25265061

6

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer.

Mooranian A, Negrulj R, Chen-Tan N, Watts GF, Arfuso F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Drug Des Devel Ther. 2014 Sep 29;8:1673-83. doi: 10.2147/DDDT.S68247. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25302020 Free PMC article.

7

Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes.

Negrulj R, Mooranian A, Chen-Tan N, Al-Sallami HS, Mikov M, Golocorbin-Kon S, Fakhoury M, Watts GF, Arfuso F, Al-Salami H. Negrulj R, et al. Artif Cells Nanomed Biotechnol. 2016 Aug;44(5):1290-7. doi: 10.3109/21691401.2015.1024845. Epub 2015 Mar 26. Artif Cells Nanomed Biotechnol. 2016. PMID: 25811999 Free article.

8

The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study.

Mooranian A, Negrulj R, Arfuso F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Drug Deliv Transl Res. 2015 Oct;5(5):511-22. doi: 10.1007/s13346-015-0248-9. Drug Deliv Transl Res. 2015. PMID: 26242686

9

Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: Formulation characterization and effects on production of insulin and inflammation in a pancreatic β-cell line.

Mooranian A, Negrulj R, Arfuso F, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Artif Cells Nanomed Biotechnol. 2016 Nov;44(7):1642-53. doi: 10.3109/21691401.2015.1069299. Epub 2015 Sep 17. Artif Cells Nanomed Biotechnol. 2016. PMID: 26377035 Free article.

10

The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies.

Mooranian A, Negrulj R, Al-Salami H. Mooranian A, et al. Among authors: negrulj r. Drug Deliv Transl Res. 2016 Feb;6(1):17-23. doi: 10.1007/s13346-015-0268-5. Drug Deliv Transl Res. 2016. PMID: 26671765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters